Early-stage researchers can greatly benefit from education and skills development in venture creation and commercialization of discoveries.
References
Chatterji, A. K., Fabrizio, K. R., Mitchell, W. & Schulman, K. A. Health Aff. (Millwood) 27, 1532–1543 (2008).
Lowe, D. Where drugs come from: the numbers. Science https://www.science.org/content/blog-post/where-drugs-come-numbers (2010).
Ozdemir, D., Dabic, M. & Daim, T. Technol. Soc. 58, 101–113 (2019).
Khanna, I. Drug Discov. Today 17, 1088–1102 (2012).
Kirsh, D. Exploring FDA approval pathways for medical devices. MassDevice (12 September 2019); https://www.massdevice.com/exploring-fda-approval-pathways-for-medical-devices/
Koons, L. The top 7 reasons why medical devices fail. Boyd Biomedical (6 December 2018); https://www.boydtech.com/articles/the-top-7-reasons-why-medical-devices-fail
Emulate. Nearly 90 percent of drug candidates fail to reach the market. Can organ-chips help? STAT (26 March 2021); https://www.statnews.com/sponsor/2021/03/26/nearly-90-percent-of-drug-candidates-fail-to-reach-the-market-can-organ-chips-help/
The Martin Trust Center for MIT Entrepreneurship. Courses, https://entrepreneurship.mit.edu/courses/ (accessed 28 July 2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vizgan, G., Hill-Whilton, Z., Achuonjei, J. et al. Longitudinal data support university-based biomedical entrepreneurship education programs. Nat Biotechnol 41, 429–431 (2023). https://doi.org/10.1038/s41587-023-01701-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01701-2
- Springer Nature America, Inc.
This article is cited by
-
Sharing best practices for educational programs on venture creation and commercialization
Nature Biotechnology (2024)